text.skipToContent text.skipToNavigation
Pharma & Biotech

Human Naïve CD8+/CD45RA+ T Cells

Catalog #: 4W-302
Human CD8+/CD45RA+ naïve cytotoxic T cells, isolated from peripheral blood using negative immunomagnetic selection, ≥ 5 million cells, cryopreserved
Compare
EA

Product Overview

Leukapheresed Naïve CD8+ T cells are isolated using a two step isolation process. CD8+ T Cells are first negatively selected from MNC using an indirect immunomagnetic CD8+ labeling system. CD45RO microbeads are then used to deplete the CD45RO+ population, leaving a highly enriched CD4+ CD45RA+ Naïve T Cell population. Cells are cryopreserved in Lonza Cryo Media and collected in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using AO/PI. Cells are collected from healthy donors following IRB protocols. Manufactured by AllCells®

Content & Storage

Content

1 vial containing ≥ 5 million cryopreserved cells

Instructions

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Need a Quote or Any Support?

Request a local representative to get back to you with additional information or pricing.

Immunotherapy and Hematopoietic Knowledge Center

The Immunotherapy and Hematopoietic Knowledge Center is dedicated to sharing interesting articles and resources related to immuno and hematopoietic research.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok